Methyl 4-(hydroxymethyl)-3-methoxybenzoate, 95.0%, 100mg

5-Bromobenzo[d]thiazol-2(3H)-one, 95.0%, 100mg

1-Phenylpiperidine-2-carboxylic acid, 95.0%, 250mg

(S)-3-Amino-1-chloro-4-phenylbutan-2-one hydrochloride, 97%, 250mg

2-Chloro-1-phenylpropan-1-one, 95.0%, 1g

2-Butenoic acid, 3-methyl-, (1R)-1-(1,4-dihydro-5,8-dihydroxy-1,4-dioxo-2-naphthalenyl)-4-methyl-3-penten-1-yl ester, 5mg

Methyl 2-amino-6-methyl-4,5,6,7-tetrahydrothieno-[2,3-c]pyridine-3-carboxylate, 95.0%, 1g

(1-(HYDROXYMETHYL)CYCLOPROPYL)(PIPERIDIN-4-YL)METHANOL, 95.0%, 250mg

Microliter syringe MICROLITER® series 700 Point type 3, 50 µl, 705 NR, 1 piece

1-methyl-2-(3-piperidinyl)-1H-benzimidazole dihydrochloride, 95.0%, 1g

2-Chloro-4-(trifluoromethoxy)aniline, 99.0%, 25g

N,N'-[(1R,2R)-1,2-Diphenyl-1,2-ethanediyl]bis[2-diphenylphosphinobenzamide], 97%, 100mg

(S)-2-(3-((1R,2R)-2-Aminocyclohexyl)thioureido)-N-benzyl-N,3,3-trimethylbutanamide, 98%, 1g